AU Patent

AU2023386710A1 — Synthesis of a cyclic peptide

Assigned to Janssen Pharmaceutica NV · Expires 2025-07-10 · 1y expired

What this patent protects

Processes for performing peptide synthesis, particularly for cyclic peptide synthesis are generally described. Reaction intermediates of the peptide synthesis are also described.

USPTO Abstract

Processes for performing peptide synthesis, particularly for cyclic peptide synthesis are generally described. Reaction intermediates of the peptide synthesis are also described.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023386710A1
Jurisdiction
AU
Classification
Expires
2025-07-10
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.